These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1111 related articles for article (PubMed ID: 15885389)

  • 21. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Features associated with the development of hallucinations in Parkinson's disease.
    Benbir G; Ozekmekçi S; Cinar M; Beskardes F; Apaydin H; Erginöz E
    Acta Neurol Scand; 2006 Oct; 114(4):239-43. PubMed ID: 16942542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up.
    Sinforiani E; Pacchetti C; Zangaglia R; Pasotti C; Manni R; Nappi G
    Mov Disord; 2008 Jul; 23(10):1441-5. PubMed ID: 18512749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressive dream content without daytime aggressiveness in REM sleep behavior disorder.
    Fantini ML; Corona A; Clerici S; Ferini-Strambi L
    Neurology; 2005 Oct; 65(7):1010-5. PubMed ID: 16217051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa.
    Tan A; Salgado M; Fahn S
    Mov Disord; 1996 Mar; 11(2):214-6. PubMed ID: 8684394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levodopa induced motor complications in Thai Parkinson's disease patients.
    Kulkantrakorn K; Tiamkao S; Pongchaiyakul C; Pulkes T
    J Med Assoc Thai; 2006 May; 89(5):632-7. PubMed ID: 16756048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associated factors for REM sleep behavior disorder in Parkinson disease.
    Sixel-Döring F; Trautmann E; Mollenhauer B; Trenkwalder C
    Neurology; 2011 Sep; 77(11):1048-54. PubMed ID: 21832215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid eye movement sleep behaviour disorder in young- and older-onset Parkinson disease: a questionnaire-based study.
    Mahale R; Yadav R; Pal PK
    Sleep Med; 2014 Jun; 15(6):642-6. PubMed ID: 24780134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
    Stacy M; Bowron A; Guttman M; Hauser R; Hughes K; Larsen JP; LeWitt P; Oertel W; Quinn N; Sethi K; Stocchi F
    Mov Disord; 2005 Jun; 20(6):726-33. PubMed ID: 15719426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
    Dhawan V; Dhoat S; Williams AJ; Dimarco A; Pal S; Forbes A; Tobías A; Martinez-Martin P; Chaudhuri KR
    J Neurol Sci; 2006 Oct; 248(1-2):158-62. PubMed ID: 16780888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease.
    Romenets SR; Gagnon JF; Latreille V; Panniset M; Chouinard S; Montplaisir J; Postuma RB
    Mov Disord; 2012 Jul; 27(8):996-1003. PubMed ID: 22733427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical manifestations of Parkinson disease and the onset of rapid eye movement sleep behavior disorder.
    Gong Y; Xiong KP; Mao CJ; Shen Y; Hu WD; Huang JY; Han F; Chen R; Liu CF
    Sleep Med; 2014 Jun; 15(6):647-53. PubMed ID: 24841108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone not associated with violent dreams or REM sleep behavior disorder in men with Parkinson's.
    Chou KL; Moro-De-Casillas ML; Amick MM; Borek LL; Friedman JH
    Mov Disord; 2007 Feb; 22(3):411-4. PubMed ID: 17230453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease.
    Gagnon JF; Vendette M; Postuma RB; Desjardins C; Massicotte-Marquez J; Panisset M; Montplaisir J
    Ann Neurol; 2009 Jul; 66(1):39-47. PubMed ID: 19670440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
    Maurel F; Lilliu H; Le Pen C
    Rev Neurol (Paris); 2001 May; 157(5):507-14. PubMed ID: 11438770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rapid-eye-movement sleep disorders in Parkinson's disease].
    Gagnon JF; Montplaisir J; Bédard MA
    Rev Neurol (Paris); 2002 Feb; 158(2):135-52. PubMed ID: 11965170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.